Vijodent - Company finances
|
EUR
|
2023
From: 2023-11-20
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 0 | 10,315 | 16,950 |
| Profit before tax | 0 | 5,212 | 5,791 |
| Net profit | 0 | 5,212 | 5,791 |
| Equity | 0 | 5,212 | 11,153 |
| Liabilities | 0 | 0 | 82 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 0 | 5,212 | 11,235 |
| Total assets | 0 | 5,212 | 11,235 |
|
Taxes paid
|
|||
| STI taxes | 62 | 304 | 892 |
|
Financial indicators
|
|||
| Revenue change y/y | - | - | +64.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | 100.0% | 51.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 100.0% | 51.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 50.5% | 34.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 50.5% | 34.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 7,092 | 8,475 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vijodent - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-10 | 2025-02-10 | 1.37 |
| 2025-01-16 | 2025-02-06 | 1.37 |
Vijodent - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Vijodent is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 0.88 |
| 2026-08-31 | 2026-08-31 | 0.76 |
| 2026-08-12 | 2026-08-30 | 0.44 |
| 2026-08-02 | 2026-08-09 | 0.44 |
| 2026-06-01 | 2026-06-05 | 0.46 |
| 2026-05-31 | 2026-05-31 | 0.36 |
| 2026-04-28 | 2026-05-30 | 0.21 |
| 2026-02-21 | 2026-03-12 | 1.73 |
| 2026-01-01 | 2026-02-03 | 1.52 |
| 2025-12-22 | 2025-12-31 | 1.48 |
| 2025-12-20 | 2025-12-21 | 50.79 |
| 2025-12-17 | 2025-12-19 | 1.48 |
| 2025-12-08 | 2025-12-16 | 1.3 |
| 2025-12-06 | 2025-12-07 | 49.85 |
| 2025-12-01 | 2025-12-05 | 1.3 |
| 2025-11-09 | 2025-11-30 | 1.07 |
| 2025-11-08 | 2025-11-08 | 50.8 |
| 2025-11-02 | 2025-11-07 | 1.07 |
| 2025-10-03 | 2025-11-01 | 1.05 |
| 2025-10-02 | 2025-10-02 | 0.9 |
| 2025-09-30 | 2025-10-01 | 0.78 |
| 2025-09-01 | 2025-09-29 | 0.65 |
| 2025-08-31 | 2025-08-31 | 0.61 |
| 2025-08-01 | 2025-08-30 | 0.45 |
| 2025-07-31 | 2025-07-31 | 0.42 |
| 2025-07-01 | 2025-07-30 | 0.28 |
| 2025-06-30 | 2025-06-30 | 0.16 |
| 2025-06-14 | 2025-06-14 | 50.92 |
| 2025-06-02 | 2025-06-13 | 0.12 |
| 2024-12-08 | 2024-12-18 | 0.87 |
| 2024-12-03 | 2024-12-07 | 0.72 |
| 2024-12-01 | 2024-12-02 | 0.61 |
| 2024-11-01 | 2024-11-30 | 0.45 |
| 2024-10-01 | 2024-10-31 | 0.24 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vijodent, MB (code 306630133) is a Small partnership engaged in dental practice care activities. In 2025, the company generated revenue of €16.9K, up 64.3% year on year from €10.3K in 2024. Net profit increased from €5.2K in 2024 to €5.8K in 2025, while the net profit margin declined from 50.5% to 34.2% as revenue expanded faster than profit. The two-year trajectory shows growth in both turnover and earnings, although profitability moderated in 2025 relative to the previous year. At the end of 2025, total assets and equity were both €11.2K, with liabilities of €82, indicating a very low leverage position and an equity ratio of 99.3%. Reported returns were strong, with ROE at 51.9% and ROA at 51.5%, supported by asset turnover of 1.51x. Productivity indicators show revenue per employee of €8.5K and profit per employee of €2.9K for 2025. Overall, the company remained profitable and lightly leveraged in the latest financial year.